Supernus Pharmaceuticals Stock Forecast

Hold candidate since Jul 27, 2026 Loss -0.87%

The Supernus Pharmaceuticals stock price fell by -2.43% on the last day (Wednesday, 29th Jul 2026) from $47.73 to $46.57. During the last trading day the stock fluctuated 4.13% from a day low at $46.09 to a day high of $48.00. The price has been going up and down for this period, and there has been a -2.43% loss for the last 2 weeks. Volume has increased on the last day by 33 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 496 thousand shares were bought and sold for approximately $23.10 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -4.34% during the next 3 months and, with a 90% probability hold a price between $40.65 and $48.01 at the end of this 3-month period.

SUPN Signals & Forecast

The Supernus Pharmaceuticals stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $47.07. On a fall, the stock will find some support from the long-term average at approximately $46.52. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Friday, July 24, 2026, and so far it has risen 0.80%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Supernus Pharmaceuticals stock

Supernus Pharmaceuticals finds support from accumulated volume at $44.75 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $1.90 (4.13%) between high and low. For the last week, the stock has had daily average volatility of 3.71%.

Our recommended stop-loss: $44.27 (-4.95%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (SUPN) For The Upcoming Trading Day Of Thursday 30th

For the upcoming trading day on Thursday, 30th we expect Supernus Pharmaceuticals to open at $46.89, and during the day (based on 14 day Average True Range), to move between $45.78 and $47.36, which gives a possible trading interval of +/-$1.57 (+/-3.43%) up or down from last closing price. If Supernus Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 3.43% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $46.84 (0.58%) than the support at $44.75 (3.91%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Supernus Pharmaceuticals stock A Buy?

Supernus Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.925 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 30, 2026 - $46.89 ( 0.676%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk